Key facts
- It has raised $3.0M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Album VC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for RxERP
- ·The full record, as it builds
Funding rounds
No funding rounds for RxERP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RxERP
Developer of a pharmaceutical supply chain management platform designed to improve automation, workflow, and security.The company offers a serialized system intended to provide real-time reporting available to the executive team, fully automated accounting reconciliation, inventory management, and serialization integration, enabling manufacturers, wholesale, distributors, and third-party logistics providers to improve operations, compliance, transparency, and efficiency.
- Sector
- Healthcare
- HQ
- Saint George, UT, United States
- Founded
- 2019
- Website
- rxerp.com/
- Ownership
- Privately Held (backing)
RxERP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RxERP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RxERP in its N-PORT filings yet. We sweep new filings monthly.